Forest plot of relative risks of not achieving SVR12 with 12 weeks of... | Download Scientific Diagram
Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data | PLOS ONE
Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C
HepDart) Ledipasvir/Sofosbuvir (LDV/SOF) for 8 Weeks in Genotype 1 (GT1) Treatment-Naïve (TN) Non-Cirrhotic (NC) Patients with HCV Viral load (VL) <6 million IU/ml (6M); A Comparative Analysis of the Phase-3 ION-3 Efficacy
Antiviral activity of LDV and SOF as monotherapy (A) and combination... | Download Scientific Diagram
Resistencias al virus de la hepatitis C. Implicaciones y posibilidades terapéuticas | Gastroenterología y Hepatología
Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/ LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV) | Scientific Reports
Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C - ScienceDirect
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study | PLOS ONE
Simulation plot predicting the probability of LDV-resistant mutant... | Download Scientific Diagram
Six weeks of sofosbuvir/ledipasvir (SOF/LDV) are sufficient to treat acute hepatitis C virus genotype 1 monoinfection: The HepNet Acute HCV IV Study
Incremental cost and effectiveness of SOF/LDV and SOF/VEL relative to... | Download Scientific Diagram
EVALUACION DE LA EFICACIA Y SEGURIDAD DE LOS TRATAMIENTOS CON LOS NUEVOS ANTIVIRALES DIRECTOS DEL VHC EN PACIENTES COINFECTADOS
RESCATE DE LOS PACIENTES CON HEPATITIS C QUE HAN FALLADO A TERAPIAS BASADAS EN ANTIVIRALES DE ACCIÓN DIRECTA. EXPERIENCIA EN VI
Treatment outcomes for SOF/LDV without RBV for HCV genotype 1 (1a, 1b,... | Download Scientific Diagram
Respuestas para un nuevo abordaje de la hepatitis C
Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study | BMJ Open
Informe de Posicionamiento Terapéutico de ledipasvir/sofosbuvir (Harvoni®)
Treatment groups by regimen. SOF, sofosbuvir; LDV, ledipasvir; SIM,... | Download Scientific Diagram
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
Pooling SAE rates of SOFL/LDV regimen on HCV genotype 6. SAE, serious... | Download Scientific Diagram
Combinación de ledipasvir/sofosbuvir como tratamiento de la infección crónica por hepatitis C | Anales de Pediatría
